Abstract
Seven hundred and thirty-three atopic asthmatic patients were entered into two multicenter double-blind double-placebo controlled studies comparing the prophylactic effects of ketotifen (445 patients), placebo (143 patients), disodium cromoglycate (72 patients) and theophylline (73 patients). The primary measure of therapeutic effects was a decrease in concomitant medication without a significant increase in symptomatology or a decrement in pulmonary function: in both studies ketotifen was shown to be an effective and safe therapeutic agent at an oral dose of 1 mg bid. The positive control, DSCG, was also shown to be effective when used properly, while theophylline did not show a significant prophylactic effect.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.